siSOD1-005M3-AC1VP

siSOD1-005M3-AC1VP is a code name for an investigational drug candidate targeting amyotrophic lateral sclerosis (ALS) associated with mutations in the superoxide dismutase 1 (SOD1) gene. Based on its nomenclature, "si" suggests it is a small interfering RNA (siRNA) designed to silence or reduce expression of the SOD1 gene, which is implicated in certain familial forms of ALS. The drug likely works by specifically binding to SOD1 mRNA and promoting its degradation, thereby reducing production of the toxic mutant SOD1 protein that contributes to motor neuron degeneration in ALS. No public information was found regarding clinical trial results, approval status, or specific developers for this exact code name.